European growth private equity investor Keensight Capital has promoted Magdalena Svensson to partner.
Svensson has 17 years of experience in the private equity industry. Having started her career in 1998 in Sweden at Swedbank, she joined the Paris office of ABN Amro Capital in 2000 where she was involved in over 20 investments.
She subsequently joined XAnge Private Equity in 2004, following its acquisition of ABN Amro Capital’s activities, first as investment director and then as partner from 2012. In the context of her different positions, Svensson has acquired specific know-how in various sectors, including technology and healthcare.
Svensson joined Keensight as investment director in 2014. In 2016, she participated actively in the creation of the Italian group Demetra which combines Tecres SpA (based in Italy) and aap Biomaterials GmbH (based in Germany), and was bought out by Keensight Capital, in order to become a leader of the bone cement and biomaterials for orthopaedic sector. In 2017, she conducted the investment in Unither, a pharmaceutical contract development manufacturing organisation (CDMO), world leader in blow-fill-seal (BFS) technology.
